Aytu Biopharma (AYTU) Shares Outstanding (2014 - 2026)
Aytu Biopharma's (AYTU) quarterly Shares Outstanding (Entity) came in at $664095.0 in Q4 2020, up 540.62% year-on-year from $103665.0 in Q1 2020, and up 5.55% on a QoQ basis from $629187.0 in Q3 2020.
Aytu Biopharma (AYTU) Shares Outstanding (2014 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 3 years of Shares Outstanding (Entity) data on file, last reported at $664095.0 in Q4 2020.
- On a quarterly basis, Shares Outstanding (Entity) rose 540.62% year-over-year to $664095.0 in Q4 2020; TTM through Dec 2020 was $664095.0, a 540.62% increase from a year earlier, with the FY2020 full-year figure at $225960.0, up 479.8% from the prior year.
- Shares Outstanding (Entity) for Q4 2020 stood at $664095.0, up from $629187.0 in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for AYTU reached as high as $664095.0 in Q4 2020 and fell as low as $2964.0 in Q1 2018.
- Historically, Shares Outstanding (Entity) has averaged $168429.1 across 3 years, with a median of $67605.0 in 2019.
- On a YoY basis, Shares Outstanding (Entity) climbed as much as 1428.51% in 2019 and fell as far as 220.1% in 2019.
- Year by year, Shares Outstanding (Entity) stood at $32385.0 in 2018, then soared by 220.1% to $103665.0 in 2019, then surged by 540.62% to $664095.0 in 2020.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $664095.0 in Q4 2020, $629187.0 in Q3 2020, and $225960.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn | 10.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.51 Mn |
| Dec 31, 2025 | 13.52 Mn |
| Sep 30, 2025 | 9.44 Mn |
| Jun 30, 2025 | 14.38 Mn |
| Mar 31, 2025 | 6.13 Mn |
| Dec 31, 2024 | 6.13 Mn |
| Sep 30, 2024 | 6.07 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 5.53 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 5.48 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 3.73 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 2.52 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 1.32 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 837,334.00 |